Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23873690)

1.

Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.

Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S, Mukhopadhyay ND, Shao C, Sarkar D, Fisher PB.

Clin Cancer Res. 2013 Sep 1;19(17):4621-33. doi: 10.1158/1078-0432.CCR-13-0585. Epub 2013 Jul 19.

2.

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.

Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S.

PLoS One. 2012;7(1):e29989. doi: 10.1371/journal.pone.0029989. Epub 2012 Jan 13.

3.

MDA-9/syntenin is a key regulator of glioma pathogenesis.

Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emdad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB.

Neuro Oncol. 2014 Jan;16(1):50-61. doi: 10.1093/neuonc/not157. Epub 2013 Dec 4.

4.

MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.

Aissaoui H, Prévost C, Boucharaba A, Sanhadji K, Bordet JC, Négrier C, Boukerche H.

J Biol Chem. 2015 Feb 6;290(6):3333-48. doi: 10.1074/jbc.M114.606913. Epub 2014 Dec 10.

PMID:
25505176
5.

Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.

Hwangbo C, Kim J, Lee JJ, Lee JH.

Cancer Res. 2010 Feb 15;70(4):1645-55. doi: 10.1158/0008-5472.CAN-09-2447. Epub 2010 Feb 9.

6.

Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation.

Nicolle G, Daher A, Maillé P, Vermey M, Loric S, Bakkar A, Wallerand H, Vordos D, Vacherot F, de Medina SG, Abbou CC, Van der Kwast T, Thiery JP, Radvanyi F, Chopin DK.

Clin Cancer Res. 2006 May 1;12(9):2937-43.

7.

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.

Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H, Lu H.

J Hematol Oncol. 2012 Jul 11;5:16. doi: 10.1186/1756-8722-5-16.

8.

mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.

Boukerche H, Su ZZ, Prévot C, Sarkar D, Fisher PB.

Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15914-9. doi: 10.1073/pnas.0808171105. Epub 2008 Oct 2.

9.

Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.

Boukerche H, Aissaoui H, Prévost C, Hirbec H, Das SK, Su ZZ, Sarkar D, Fisher PB.

Oncogene. 2010 May 27;29(21):3054-66. doi: 10.1038/onc.2010.65. Epub 2010 Mar 15.

10.

Overexpression of syntenin enhances hepatoma cell proliferation and invasion: potential roles in human hepatoma.

Liu X, Zhang X, Lv Y, Xiang J, Shi J.

Oncol Rep. 2014 Dec;32(6):2810-6. doi: 10.3892/or.2014.3498. Epub 2014 Sep 18.

PMID:
25242117
11.

MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.

Oyesanya RA, Bhatia S, Menezes ME, Dumur CI, Singh KP, Bae S, Troyer DA, Wells RB, Sauter ER, Sidransky D, Fisher PB, Semmes OJ, Dasgupta S.

Oncoscience. 2014 Sep 18;1(11):725-37. eCollection 2014.

12.

mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.

Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB.

Cancer Res. 2007 Feb 15;67(4):1812-22.

13.

Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.

Kim WY, Jang JY, Jeon YK, Chung DH, Kim YG, Kim CW.

Exp Mol Med. 2014 Apr 11;46:e90. doi: 10.1038/emm.2014.1.

14.

MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.

Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, Dasgupta S, Dash R, Dent P, Grant S, Emdad L, Pellecchia M, Sarkar D, Fisher PB.

Cancer Res. 2013 Jan 15;73(2):844-54. doi: 10.1158/0008-5472.CAN-12-1681. Epub 2012 Dec 10.

15.

SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling.

Dasgupta S, Jang JS, Shao C, Mukhopadhyay ND, Sokhi UK, Das SK, Brait M, Talbot C, Yung RC, Begum S, Westra WH, Hoque MO, Yang P, Yi JE, Lam S, Gazdar AF, Fisher PB, Jen J, Sidransky D.

J Mol Med (Berl). 2013 Mar;91(3):381-93. doi: 10.1007/s00109-012-0955-3. Epub 2012 Sep 12.

16.

mda-9/Syntenin: a positive regulator of melanoma metastasis.

Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB.

Cancer Res. 2005 Dec 1;65(23):10901-11.

17.
18.

Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.

Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F, Reiter RR.

Urol Oncol. 2010 Mar-Apr;28(2):180-8. doi: 10.1016/j.urolonc.2008.09.041. Epub 2008 Dec 12.

PMID:
19070520
19.

The tandem PDZ domains of syntenin promote cell invasion.

Meerschaert K, Bruyneel E, De Wever O, Vanloo B, Boucherie C, Bracke M, Vandekerckhove J, Gettemans J.

Exp Cell Res. 2007 May 15;313(9):1790-804. Epub 2007 Mar 24.

PMID:
17451681
20.

EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.

Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.

Amino Acids. 2012 Nov;43(5):2027-35. doi: 10.1007/s00726-012-1277-z. Epub 2012 Apr 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk